| RS1603337052 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS1603338257 |
PHF8
|
Health Risk |
Pathogenic |
— |
| RS1603339671 |
PHF8
|
Health Risk |
Pathogenic |
— |
| RS1603340281 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1603340353 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1603341328 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Severe neonatal-onset encephalopathy with microcephaly |
| RS1603341359 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS1603342258 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1603342313 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1603342316 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1603342339 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1603343101 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1603343235 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS1603346587 |
BRIP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1603346830 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1603346857 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS1603346983 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1603347042 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1603347058 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1603350606 |
AFF2
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1603358246 |
FLNA
|
Health Risk |
Pathogenic |
Oto-palato-digital syndrome, type II |
| RS1603358919 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS1603359091 |
FLNA
|
Health Risk |
Likely pathogenic |
Prune belly syndrome, Prune belly syndrome |
| RS1603359205 |
FLNA
|
Health Risk |
Likely pathogenic |
Prune belly syndrome, Prune belly syndrome |
| RS1603359417 |
FLNA
|
Health Risk |
Likely pathogenic |
— |
| RS1603359437 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontometaphyseal dysplasia, Oto-palato-digital syndrome |
| RS1603359464 |
FLNA
|
Health Risk |
Pathogenic |
Oto-palato-digital syndrome, type II |
| RS1603359848 |
MAGT1
|
Health Risk |
Likely pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS1603360542 |
FLNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiac valvular dysplasia, X-linked |
| RS1603360547 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS1603360728 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotopia, periventricular |
| RS1603360906 |
FLNA
|
Health Risk |
Likely pathogenic |
Melnick-Needles syndrome, Frontometaphyseal dysplasia |
| RS1603361195 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Frontometaphyseal dysplasia |
| RS1603361427 |
MAGT1
|
Health Risk |
Pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS1603361428 |
MAGT1
|
Health Risk |
Likely pathogenic |
— |
| RS1603361558 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1603361570 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1603361577 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1603361587 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1603361606 |
MAGT1
|
Health Risk |
Pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS1603361705 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1603361729 |
MAGT1
|
Health Risk |
Pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS1603361795 |
MAGT1
|
Health Risk |
Pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS1603361804 |
MAGT1
|
Health Risk |
Pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS1603361811 |
MAGT1
|
Health Risk |
Likely pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS1603361851 |
FLNA
|
Health Risk |
Pathogenic |
Oto-palato-digital syndrome, type II |
| RS1603361938 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1603362402 |
FLNA
|
Health Risk |
Pathogenic |
Cardiac valvular dysplasia, X-linked |
| RS1603362580 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS1603362622 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1603362725 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1603362871 |
FLNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Melnick-Needles syndrome, Heterotopia |
| RS1603365762 |
EMD
|
Health Risk |
Likely pathogenic |
Primary familial dilated cardiomyopathy, Primary familial dilated cardiomyopathy |
| RS1603366250 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS1603366351 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1603367647 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS1603367649 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1603367673 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS1603367753 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS1603368431 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1603368490 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1603368491 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1603370185 |
UPF3B
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability 14, Syndromic X-linked intellectual disability 14 |
| RS1603371016 |
UPF3B
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability 14, Syndromic X-linked intellectual disability 14 |
| RS1603373827 |
PAK3
|
Health Risk |
Pathogenic |
Microcephaly, Intellectual disability |
| RS1603376560 |
TAFAZZIN
|
Health Risk |
Likely pathogenic |
3-Methylglutaconic aciduria type 2, 3-Methylglutaconic aciduria type 2 |
| RS1603376833 |
TAFAZZIN
|
Health Risk |
Pathogenic |
3-Methylglutaconic aciduria type 2, Thyroid cancer |
| RS1603376938 |
TAFAZZIN
|
Health Risk |
Likely pathogenic |
3-Methylglutaconic aciduria type 2, 3-Methylglutaconic aciduria type 2 |
| RS1603377590 |
TAFAZZIN
|
Health Risk |
Pathogenic |
3-Methylglutaconic aciduria type 2, 3-Methylglutaconic aciduria type 2 |
| RS1603377747 |
TAFAZZIN
|
Health Risk |
Pathogenic |
3-Methylglutaconic aciduria type 2, 3-Methylglutaconic aciduria type 2 |
| RS1603377813 |
PAK3
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 30 |
| RS1603377936 |
TAFAZZIN
|
Health Risk |
Likely pathogenic |
Left ventricular noncompaction cardiomyopathy, Left ventricular noncompaction cardiomyopathy |
| RS1603377945 |
TAFAZZIN
|
Health Risk |
Likely pathogenic |
3-Methylglutaconic aciduria type 2, Cardiovascular phenotype |
| RS1603378331 |
PAK3
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 30 |
| RS1603379772 |
NKAP
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, X-linked |
| RS1603379779 |
NKAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder, X-linked |
| RS1603379780 |
NKAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder, X-linked |
| RS1603379781 |
NKAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder, X-linked |
| RS1603381331 |
ATP7A
|
Health Risk |
Pathogenic |
Cutis laxa, X-linked |
| RS1603381671 |
TAFAZZIN
|
Health Risk |
Pathogenic |
3-Methylglutaconic aciduria type 2, 3-Methylglutaconic aciduria type 2 |
| RS1603381860 |
TAFAZZIN
|
Health Risk |
Pathogenic |
3-Methylglutaconic aciduria type 2, TAFAZZIN-related disorder |
| RS1603382251 |
TAFAZZIN
|
Health Risk |
Likely pathogenic |
— |
| RS1603387278 |
ATP7A
|
Health Risk |
Likely pathogenic |
Menkes kinky-hair syndrome, Menkes kinky-hair syndrome |
| RS1603388837 |
RAX
|
Health Risk |
Pathogenic |
Isolated microphthalmia 3, Isolated microphthalmia 3 |
| RS1603389393 |
ATP7A
|
Health Risk |
Pathogenic |
Cutis laxa, X-linked |
| RS1603391120 |
ATP7A
|
Health Risk |
Pathogenic |
X-linked distal spinal muscular atrophy type 3, Menkes kinky-hair syndrome |
| RS1603391127 |
ATP7A
|
Health Risk |
Likely pathogenic |
Menkes kinky-hair syndrome, Menkes kinky-hair syndrome |
| RS1603392097 |
MED13
|
Health Risk |
Pathogenic |
— |
| RS1603392856 |
MED13
|
Health Risk |
Pathogenic |
— |
| RS1603393478 |
PISD
|
Health Risk |
Pathogenic/Likely pathogenic |
PISD-related mitochondrial disease, Liberfarb syndrome |
| RS1603394630 |
MED13
|
Health Risk |
Pathogenic |
— |
| RS1603396835 |
MED13
|
Health Risk |
Pathogenic |
— |
| RS1603400699 |
MAPRE2
|
Health Risk |
Likely pathogenic |
Skin creases, congenital symmetric circumferential |
| RS1603401125 |
ACSL4
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1603404297 |
IGSF1
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked central congenital hypothyroidism with late-onset testicular enlargement, X-linked central congenital hypothyroidism with late-onset testicular enlargement |
| RS1603404413 |
IGSF1
|
Health Risk |
Pathogenic |
X-linked central congenital hypothyroidism with late-onset testicular enlargement, X-linked central congenital hypothyroidism with late-onset testicular enlargement |
| RS1603404421 |
IGSF1
|
Health Risk |
Pathogenic |
X-linked central congenital hypothyroidism with late-onset testicular enlargement, X-linked central congenital hypothyroidism with late-onset testicular enlargement |
| RS1603405457 |
MED13
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder 61, Intellectual developmental disorder 61 |
| RS1603410966 |
MED13
|
Health Risk |
Pathogenic |
— |
| RS1603411177 |
G6PD
|
Health Risk |
Pathogenic |
Anemia, nonspherocytic hemolytic |